Folate status and colorectal cancer risk: A 2016 update

Molecular Aspects of Medicine

Volumn 53, Issue , 2017, Pages 73-79

  Mason, Joel B ^a,c   Tang, San Yuan ^b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN B GROUP; WNT PROTEIN;

ALCOHOL CONSUMPTION; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; CONSENSUS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FATHER; FOLIC ACID BLOOD LEVEL; GENETIC STABILITY; GENETIC VARIATION; HUMAN; MATERNAL NUTRITION; NONHUMAN; PROGENY; REVIEW; VITAMIN INTAKE; WNT SIGNALING PATHWAY; COLORECTAL TUMOR; METABOLISM; RISK FACTOR;

COLORECTAL NEOPLASMS; FOLIC ACID; HUMANS; RISK FACTORS;

EID: 85008156009     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2016.11.010     Document Type: Review

References (93)

1. Ajrouche, R., Rudant, J., Orsi, L., et al. Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE study. Cancer Causes Control 25 (2014), 1283–1293.
2. Barker, D.J., The developmental origins of adult disease. J. Am. Coll. Nutr. 23:Suppl 6 (2004), 588S–595S.
3. Bailey, R., Mills, J., Yetley, E., et al. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States. Am. J. Clin. Nutr. 92 (2010), 383–389.
4. Bird, J., Ronnenberg, A., Choi, S.W., et al. Obesity is associated with increased red blood cell folate despite lower dietary intakes and serum concentrations. J. Nutr. 145 (2015), 79–86 doi: 10.3945.
5. Chen, J., Xu, X., Liu, A., Ulrich, C., Folate and cancer: epidemiological perspective. Bailey, L., (eds.) Folate in Health and Disease, second ed., 2010, Taylor & Francis LLC, Boca Raton, FL, 205–234.
6. Cho, K., Mabasa, L., Bae, S., et al. Maternal high-methyl diet suppresses mammary carcinogenesis in female rat offspring. Carcinogenesis 33 (2012), 1106–1112.
7. Cho, E., Zhang, X., Townsend, M.K., et al. Unmetabolized folic acid in prediagnostic plasma and the risk of colorectal cancer. J. Natl. Cancer Inst., 107, 2015 djv260.
8. Choi, S.W., Friso, S., Ghandour, H., et al. Vitamin B-12 deficiency induces anomalies of base substitution and methylation in the DNA of rat colonic epithelium. J. Nutr. 134 (2004), 750–755.
9. Chokkalingam, A., Chun, D., Noonan, E., et al. Blood levels of folate at birth and risk of childhood leukemia. Cancer Epidemiol. Biomarkers Prev. 22 (2013), 1088–1094.
10. Ciappio, E., Mason, J.B., Folate and cancer: mechansims. Bailey, L., (eds.) Folate in Health and Disease, second ed., 2010, Taylor & Francis LLC, Boca Raton, FL, 235–262.
11. Ciappio, E., Liu, Z., Brooks, R., et al. Maternal B vitamin supplementation from preconception through weaning suppresses intestinal tumorigenesis in Apc1638N mouse offspring. Gut 60 (2011), 1695–1702.
12. Cole, B., Baron, J., Sandler, R., Polyp Prevention Study Group, et al. Folic acid for the prevention of colorectal adenomas. JAMA 297 (2007), 2351–2359.
13. Collin, S., Metcalfe, C., Refsum, H., et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 19 (2010), 1632–1642.
14. Cooney, C.A., Dave, A.A., Wolff, G.L., Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr., 132(Suppl. 8), 2002 2393S–400S.
15. Ebbing, M., Bønaa, K.H., Nygård, O., et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302 (2009), 2119–2126.
16. Eussen, S., Vollset, S., Igland, J., et al. Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol. Biomarkers Prev. 2010:19 (2010), 1328–1340.
17. Farber, S., Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood 4 (1949), 160–167.
18. Figueiredo, J., Grau, M., Haile, R., Folic acid and risk of prostate Cancer: results from a randomized clinical trial. J. Natl. Cancer Inst. 101 (2009), 432–435.
19. Figueiredo, J., Mott, L., Giovannucci, E., et al. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int. J. Cancer 129 (2011), 192–203.
20. Figueiredo, J., Levine, A., Crott, J., Baurley, J., Haile, R., Folate-genetics and colorectal neoplasia: what we know and need to know next. Mol. Nutr. Food Res. 57 (2013), 607–627.
21. French, A., Grant, R., Weitzman, S., et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin. Pharmacol. Ther. 74 (2003), 288–294.
22. Gibson, T., Weinstein, S., Pfeiffer, R., et al. Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am. J. Clin. Nutr. 94 (2011), 1053–1062.
23. Giovannucci, E., Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J. Nutr., 134, 2004 2475S–81S.
24. Glynn, S., Albanes, D., Pietinen, P., et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol. Biomarkers Prev. 5 (1996), 487–494.
25. Goh, Y., Bollano, E., Einarson, T., et al. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin. Pharmacol. Ther. 81 (2007), 685–691.
26. Gylling, B., Van Guelpen, B., Schneede, J., et al. Low folate levels are associated with reduced risk of colorectal Cancer in a population with low folate status. Cancer Epidemiol. Biomarkers Prev. 23 (2014), 2136–2144.
27. Heinle, R., Welch, A., Experiments with pteroylglutamic acid and pteroylglutamic acid deficiency in human leukemia [abstr]. J. Clin. Invest., 27, 1948, 539.
28. Heresbach, D., Barrioz, T., Lapalus, M., et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 40 (2008), 284–290.
29. Hustad, S., Ueland, P., Vollset, S., et al. Riboflavin as a determinant of plasma total homocysteine: effect modification by the MTHFR C677T polymorphism. Clin. Chem. 46 (2000), 1065–1071.
30. Jaszewski, R., Misra, S., Tobi, M., et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J. Gastroenterol. 14 (2008), 4492–4498.
31. Johansson, M., Relton, C., Ueland, P., et al. Serum B vitamin levels and risk of lung cancer. JAMA 303 (2010), 2377–2385.
32. Joubert, B., den Dekker, H., Felix, J., et al. Maternal plasma folate impacts differential DNA methylation in an epigenome-wide meta-analysis of newborns. Nat. Commun., 7, 2016, 10577, 10.1038/.
33. Kelly, P., McPartlin, J., Scott, J., A combined high-performance liquid chromatographic microbiological assay for serum unmetabolised folic acid. Anal. Biochem. 238 (1996), 179–183.
34. Kennedy, D., Stern, S., Matok, I., et al. Folate intake, MTHFR polymorphisms, and the risk of colorectal cancer: a systematic review and meta-analysis. J. Cancer Epidemiol. 35 (2011), 2–10.
35. Kim, Y.-I., Salomon, R., Graeme-Cook, F., et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39 (1996), 732–740.
36. Kim, Y.-I., Role of folate in colon cancer development and progression. J. Nutr., 133(11 Suppl. 1), 2003 3731S–39S.
37. Kim, Y.-I., Folate, colorectal carinogenesis, and DNA methylation: lessons from animal studies. Environ. Mol. Mutagen 44 (2004), 10–25.
38. Knock, E., Deng, L., Wu, Q., et al. Strain differences in mice highlight the role of DNA damage in neoplasia induced by low dietary folate. J. Nutr. 138 (2008), 653–658.
39. Kotsopoulos, J., Medline, A., Renlund, R., et al. Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis 26 (2005), 1603–1612.
40. Lajous, M., Lazcano-Ponce, E., Hernandez-Avila, M., Willett, W., Romieu, I., Folate, vitamin B6, and vitamin B12 intake and the risk of breast cancer among Mexican women. Cancer Epidemiol. Biomarkers Prev. 15 (2006), 443–448.
41. Lambrot, R., Xu, C., Saint-Phar, S., et al. Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes. Nat. Commun., 4, 2013, 2889.
42. Larsson, S., Giovannucci, E., Wolk, A., Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131 (2006), 1271–1283.
43. Larsson, S., Giovannucci, E., Wolk, A., Folate and risk of breast cancer: a meta-analysis. J. Natl. Cancer Inst. 99 (2007), 64–76.
44. Lee, J., Wei, E., Fuchs, C., et al. Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case–control studies. Cancer Causes Control 23 (2012), 537–545.
45. LeLeu, R., Young, G., McIntosh, G., Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 21 (2000), 2261–2265.
46. Lewis, S., Harbord, R., Harris, R., et al. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J. Natl. Cancer Inst. 98 (2006), 1607–1622.
47. Li, E., Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3 (2002), 662–673.
48. Lindenbaum, J., Rosenberg, I.H., Wilson, P., et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am. J. Clin. Nutr. 60 (1994), 2–11.
49. Liu, Z., Choi, S.W., Crott, J., et al. Mild depletion of dietary folate combined with other B-vitamins alters multiple components of the Wnt pathway in the mouse colon. J. Nutr. 137 (2007), 2701–2708.
50. Liu, Z., Choi, S.W., Crott, J., et al. Multiple B-vitamin inadequacy amplifies alterations induced by folate depletion in p53 expression and its downstream effector MDM2. Int. J. Cancer 123 (2008), 519–525.
51. Liu, Z., Ciappio, E., Crott, J., et al. Combined mild inadequacies of ‘one-carbon’ vitamins amplify colonic Wnt-signaling and promote intestinal tumorigenesis in BAT-LacZ×Apc1638N mice. FASEB J. 25 (2011), 3136–3145.
52. Logan, R., Grainge, M., Shepherd, V., et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134 (2008), 29–38.
53. Ly, A., Lee, H., Chen, J., et al. Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring. Cancer Res. 2011:71 (2011), 988–997.
54. Mason, J.B., Choi, S.W., Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol 35 (2005), 235–241.
55. Mason, J.B., Dickstein, A., Jacques, P., et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol. Biomarkers Prev. 16 (2007), 1325–1329.
56. Mason, J.B., Folate consumption and cancer risk: a confirmation and some reassurance, but we're not out of the woods quite yet. Am. J. Clin. Nutr. 94 (2011), 965–966.
57. MacFarlane, A., McEntee, M., Stover, P., Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity. J. Nutr. 144 (2014), 419–424.
58. Milne, E., Royle, J., Miller, M., et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int. J. Cancer 126 (2010), 2690–2699.
59. National Diet and Nutrition Survey, Adults Aged 19–64, vol. 4, 2004, Her Majesty's Stationery Office, London, United Kingdom Accessed 2009 www.food.gov.uk/science/dietarysurveys/ndnsdocuments/ndns4.
60. Orjuela, M., Cabrera-Munoz, L., Paul, L., et al. Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake. Cancer 118 (2012), 5912–5919.
61. Paspatis, G.A., Karamanolis, D.G., Folate supplementation and adenomatous colonic polyps. Dis. Colon Rectum 37 (1994), 1340–1341.
62. Pfeiffer, C., Sternberg, M., Fazili, Z., et al. Folate status and concentrations of serum folate form in the U.S. population. Br. J. Nutr. 113 (2015), 1965–1977.
63. Planells, E., Sanchez, C., Montellano, M., et al. Vitamins B6 and B12 and folate status in an adult Mediterranean population. Eur. J. Clin. Nutr. 57 (2003), 777–785.
64. Protiva, P., Mason, J.B., Liu, Z., et al. Altered folate availability modifies the molecular environment of the human colon: implications for colorectal carcinogenesis. Cancer Prev. Res. 4 (2011), 530–543.
65. Radimer, K., Bindewald, B., Hughes, J., et al. Dietary supplement use by US adults: data from the national health and nutrition examination survey, 1999-2000. Am. J. Epidemiol. 160 (2004), 339–349.
66. Reed, M., Nijout, H., Neuhouser, M., et al. A mathematical model gives insights into nutritional and genetic aspects of folate-mediated 1-carbon metabolism. J. Nutr. 136 (2006), 2653–2661.
67. Sabet, J., Park, L., Iyer, L., et al. Paternal B vitamin intake is a determinant of growth, hepatic lipid metabolism and intestinal tumor volume in female Apc1638N mouse offspring. PLoS One, 11, 2016, e0151579.
68. Sanjoaquin, M., Allen, N., Couto, E., et al. Folate intake and colorectal cancer risk: a meta-analytical approach. Int. J. Cancer 113 (2005), 825–828.
69. Sawaengsri, H., Wang, J., Reginaldo, C., et al. High folic acid intake reduces natural killer cell cytotoxicity in aged mice. J. Nutr. Biochem. 30 (2016), 102–107.
70. Schatzkin, A., Intermediate markers as surrogate endpoints in cancer research. Hematol. Oncol. Clin. North Am. 14 (2000), 887–905.
71. Schuz, J., Weihkopf, T., Kaatsch, P., Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur. J. Pediatr. 166 (2007), 433–441.
72. Selhub, J., Jacques, P., Bostom, A., et al. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham study population. J. Nutr., 126, 1996 1258S–65S.
73. Shpitz, B., Bomstein, Y., Mekori, Y., et al. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am. J. Surg. 174 (1997), 425–430.
74. Sie, K., Chen, J., Sohn, K., et al. Folic acid supplementation provided in utero and during lactation reduces the number of terminal end buds of the developing mammary glands in the offspring. Cancer Lett. 280 (2009), 72–77.
75. Sie, K., Medline, A., van Weel, J., et al. Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the offspring. Gut 60 (2011), 1687–1694.
76. Soetikno, R., Kaltenbach, T., Rouse, R., et al. Prevalence of nonpolypoid (flat or depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299 (2008), 1027–1035.
77. Sohn, K., Stempak, J., Reid, S., et al. The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 24 (2003), 81–90.
78. Song, J., Medline, A., Mason, J.B., et al. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res. 60 (2000), 5434–5440.
79. Song, J., Sohn, K., Medline, A., et al. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/Msh2 mice. Cancer Res. 60 (2000), 3191–3199.
80. Stevens, V., McCullough, M., Sun, J., et al. High levels of folate, from supplements and fortification, are not associated with increased risk of colorectal cancer. Gastroenterology 141 (2011), 98–105.
81. Stolzenberg-Solomon, R., Chang, S., Leitzmann, M., et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian Cancer screening trial. Am. J. Clin. Nutr. 83 (2006), 895–904.
82. Sweeney, M., McPartlin, J., Weir, D., et al. Measurements of subnanomolar concentrations of unmetabolised folic acid in serum. J. Chromatogr. 788 (2003), 187–191.
83. Sweeney, M., McPartlin, J., Weir, D., et al. Post-prandial serum folic acid response to multiple doses of folic acid in fortified bread. Br. J. Nutr. 94 (2006), 1–8.
84. Sweeney, M., McPartlin, J., Scott, J., Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health, 7, 2007, 41.
85. Thompson, J.R., Gerald, P.F., Willoughby, M.L., et al. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358 (2001), 1935–1940.
86. Troen, A., Mitchell, B., Sorensen, B., et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J. Nutr. 136 (2006), 189–194.
87. Vollset, S.E., Clarke, R., Lewington, S., et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet 381:9871 (2013), 1029–1036.
88. Wargovich, M., Chen, C., Jimenez, A., et al. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomarkers Prev. 5 (1996), 355–360.
89. Waterland, R., Jirtle, R., Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23 (2003), 5293–5300.
90. Wien, T.N., Pike, E., Wisløff, T., et al. Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open, 2, 2012, e000653 doi:10.1136/.
91. Wu, K., Helzlsouer, K., Comstock, G., et al. A prospective study on folate, B12, and PLP and breast cancer. Cancer Epidemiol. Biomarkers Prev. 8 (1999), 209–217.
92. Wu, K., Platz, E., Willett, W., et al. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am. J. Clin. Nutr. 90 (2009), 1623–1631.
93. Zhang, S., Willett, W., Selhub, J., et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J. Natl. Cancer Inst. 95 (2003), 373–380.